Our pharmaceutical injury lawyers successfully recovered $2.5 million on behalf of a 63-year-old Sacramento woman who was prescribed a diabetes drug that resulted in liver failure. The drug had been approved by the FDA, but was later recalled.
The manufacturer initially claimed that the drug was safe. However, our attorneys were able to demonstrate that the manufacturer knew about problems with impaired liver function, but never adequately warned doctors or the public about this side effect and limited any mention of possible liver damage to the “fine print” of its package insert. Because of the manufacturer’s failure to tell prescribing doctors about the problem, our client’s physicians were unaware that her liver failure was due to the drug.
